by Clinical Neuropsychologist | Thursday, June 13, 2024 | Dementia
Abstract INTRODUCTION The Boston criteria v2.0 for cerebral amyloid angiopathy (CAA) incorporated non-hemorrhagic imaging markers. Their prevalence and significance in patients with cognitive impairment remain uncertain. METHODS We studied 622 memory clinic patients...
by Clinical Neuropsychologist | Thursday, June 13, 2024 | Dementia
Abstract INTRODUCTION Despite representing an essential workforce, it is unclear how global policy efforts target early-career dementia researchers (ECDRs). Thus, this study aimed to provide an overview of policies through which ECDRs are considered and supported by...
by Clinical Neuropsychologist | Thursday, June 13, 2024 | Dementia
Abstract INTRODUCTION While observational research suggests a protective role for nutrition in brain aging, intervention studies remain inconclusive. This failing translation from observational to interventional research may result from overlooking nutrient...
by Clinical Neuropsychologist | Thursday, June 13, 2024 | Dementia
Abstract INTRODUCTION Frontotemporal lobar degeneration (FTLD) encompasses behavioral variant frontotemporal dementia (bvFTD), progressive supranuclear palsy, corticobasal syndrome/degeneration, and primary progressive aphasias (PPAs). We cross-validated fluid...
by Clinical Neuropsychologist | Thursday, June 13, 2024 | Dementia
Abstract BACKGROUND Mild cognitive impairment (MCI) heightens Alzheimer’s disease (AD) risk, with diabetes mellitus (DM) potentially exacerbating this vulnerability. This study identifies the optimal intervention period and neurobiological targets in MCI to AD...
